API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Acc 9089
2. Acc-9089
3. Flestolol
1. Flestolol Sulfate [usan]
2. Flestolol Sulphate
3. Acc-9089
4. 88844-73-9
5. T5mwt8445u
6. Acc-9089-005
7. Flestolol Sulfate (usan)
8. Benzoic Acid, 2-fluoro-, 3-((2-((aminocarbonyl)amino)-1,1-dimethylethyl)amino)-2-hydroxypropyl Ester, (+-)-, Sulfate (1:1) (salt)
9. Acc 9089
10. Unii-t5mwt8445u
11. Schembl611922
12. Chembl1742474
13. Flestolol Sulfate [mart.]
14. Dtxsid801008524
15. O-fluorobenzoic Acid, 3-ester With (+-)-(2-((2,3-dihydroxypropyl)amino)-2-methylpropyl)urea, Sulfate (1:1) (salt)
16. D04190
17. Q27289702
18. [3-[[1-(carbamoylamino)-2-methylpropan-2-yl]amino]-2-hydroxypropyl] 2-fluorobenzoate;sulfuric Acid
19. Benzoic Acid, 2-fluoro-, 3-((2-((aminocarbonyl)amino)-1,1-dimethylethyl)amino)-2-hydroxypropyl Ester, (+/-)-, Sulfate (1:1) (salt)
20. N-[2-({3-[(2-fluorobenzoyl)oxy]-2-hydroxypropyl}amino)-2-methylpropyl]carbamimidic Acid--sulfuric Acid (1/1)
21. O-fluorobenzoic Acid, 3-ester With (+/-)-(2-((2,3-dihydroxypropyl)amino)-2-methylpropyl)urea, Sulfate (1:1) (salt)
Molecular Weight | 425.4 g/mol |
---|---|
Molecular Formula | C15H24FN3O8S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 425.12681407 g/mol |
Monoisotopic Mass | 425.12681407 g/mol |
Topological Polar Surface Area | 197 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 488 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)